STEVEN BAUER: Open Payments
NPI 1053402875 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,912 in 99 payments from 26 companies in 2025. Trend: 2023 $5,733 · 2024 $2,762 · 2025 $1,912
Food & beverage: $1,912
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $477 |
| AstraZeneca Pharmaceuticals LP | 10 | $261 |
| PFIZER INC. | 19 | $187 |
| ABBVIE INC. | 11 | $165 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $120 |
| Amgen Inc. | 5 | $75 |
| Verity Pharmaceuticals Inc. | 3 | $75 |
| Lilly USA, LLC | 3 | $58 |
| Exact Sciences Corporation | 3 | $53 |
| Abbott Laboratories | 2 | $49 |
Products named: Wegovy, NURTEC ODT, BREZTRI, JARDIANCE, Ozempic, Tlando, FARXIGA, Rybelsus.
Industry payments across NC — which companies pay providers there.
